328 related articles for article (PubMed ID: 30707545)
21. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles.
Ruan S; Yuan M; Zhang L; Hu G; Chen J; Cun X; Zhang Q; Yang Y; He Q; Gao H
Biomaterials; 2015 Jan; 37():425-35. PubMed ID: 25453970
[TBL] [Abstract][Full Text] [Related]
22. Effect of Chemical Binding of Doxorubicin Hydrochloride to Gold Nanoparticles, Versus Electrostatic Adsorption, on the In Vitro Drug Release and Cytotoxicity to Breast Cancer Cells.
Zayed GM; Kamal I; Abdelhafez WA; M Alsharif F; Amin MA; Shaykoon MSA; Sarhan HA; Abdelsalam AM
Pharm Res; 2018 Mar; 35(6):112. PubMed ID: 29603025
[TBL] [Abstract][Full Text] [Related]
23. Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin release.
Basuki JS; Duong HT; Macmillan A; Erlich RB; Esser L; Akerfeldt MC; Whan RM; Kavallaris M; Boyer C; Davis TP
ACS Nano; 2013 Nov; 7(11):10175-89. PubMed ID: 24131276
[TBL] [Abstract][Full Text] [Related]
24. Effect of cationic side-chains on intracellular delivery and cytotoxicity of pH sensitive polymer-doxorubicin nanocarriers.
Fang C; Kievit FM; Cho YC; Mok H; Press OW; Zhang M
Nanoscale; 2012 Nov; 4(22):7012-20. PubMed ID: 23041969
[TBL] [Abstract][Full Text] [Related]
25. Intelligent Janus nanoparticles for intracellular real-time monitoring of dual drug release.
Cao H; Yang Y; Chen X; Shao Z
Nanoscale; 2016 Mar; 8(12):6754-60. PubMed ID: 26952741
[TBL] [Abstract][Full Text] [Related]
26. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
27. Differential toxicity of gold-doxorubicin in cancer cells vs. cardiomyocytes as measured by real-time growth assays and fluorescence lifetime imaging microscopy (FLIM).
Tawagi E; Massmann C; Chibli H; Nadeau JL
Analyst; 2015 Aug; 140(16):5732-41. PubMed ID: 26161455
[TBL] [Abstract][Full Text] [Related]
28. Nanoplatform based on GSH-responsive mesoporous silica nanoparticles for cancer therapy and mitochondrial targeted imaging.
He H; Meng S; Li H; Yang Q; Xu Z; Chen X; Sun Z; Jiang B; Li C
Mikrochim Acta; 2021 Apr; 188(5):154. PubMed ID: 33821295
[TBL] [Abstract][Full Text] [Related]
29. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
Tam YT; To KK; Chow AH
Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
[TBL] [Abstract][Full Text] [Related]
30. High-yield clicking and dissociation of doxorubicin nanoclusters exhibiting differential cellular uptakes and imaging.
Kim HS; Yoon S; Son YJ; Park Y; Jung YM; Yoo HS
J Control Release; 2015 Nov; 217():64-73. PubMed ID: 26315815
[TBL] [Abstract][Full Text] [Related]
31. AIE/FRET-based versatile PEG-Pep-TPE/DOX nanoparticles for cancer therapy and real-time drug release monitoring.
Wang TT; Wei QC; Zhang ZT; Lin MT; Chen JJ; Zhou Y; Guo NN; Zhong XC; Xu WH; Liu ZX; Han M; Gao JQ
Biomater Sci; 2020 Jan; 8(1):118-124. PubMed ID: 31777865
[TBL] [Abstract][Full Text] [Related]
32. Natural tripeptide capped pH-sensitive gold nanoparticles for efficacious doxorubicin delivery both in vitro and in vivo.
Kumar K; Moitra P; Bashir M; Kondaiah P; Bhattacharya S
Nanoscale; 2020 Jan; 12(2):1067-1074. PubMed ID: 31845927
[TBL] [Abstract][Full Text] [Related]
33. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells.
Wang F; Wang YC; Dou S; Xiong MH; Sun TM; Wang J
ACS Nano; 2011 May; 5(5):3679-92. PubMed ID: 21462992
[TBL] [Abstract][Full Text] [Related]
34. Monitoring the Cellular Delivery of Doxorubicin-Cu Complexes in Cells by Fluorescence Lifetime Imaging Microscopy.
Peng Z; Nie K; Song Y; Liu H; Zhou Y; Yuan Y; Chen D; Peng X; Yan W; Song J; Qu J
J Phys Chem A; 2020 May; 124(21):4235-4240. PubMed ID: 32364735
[TBL] [Abstract][Full Text] [Related]
35. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
[TBL] [Abstract][Full Text] [Related]
36. Doxorubicin encapsulated clicked gold nanoparticle clusters exhibiting tumor-specific disassembly for enhanced tumor localization and computerized tomographic imaging.
Mao W; Kim HS; Son YJ; Kim SR; Yoo HS
J Control Release; 2018 Jan; 269():52-62. PubMed ID: 29113793
[TBL] [Abstract][Full Text] [Related]
37. Nanoparticle-Modified Apoferritin Nanotransfer for Targeted Cytostatic Transport.
Čížek M; Gargulák M; Sehnal K; Uhlířová D; Staňková M; Dočekalová M; Ruttkay-Nedecký B; Zídková J; Kizek R
Klin Onkol; 2019; 32(3):197-200. PubMed ID: 31216851
[TBL] [Abstract][Full Text] [Related]
38. Interaction of gold nanoparticles with Doxorubicin mediated by supramolecular chemistry.
Marcelo G; Kaplan E; Tarazona MP; Mendicuti F
Colloids Surf B Biointerfaces; 2015 Apr; 128():237-244. PubMed ID: 25697809
[TBL] [Abstract][Full Text] [Related]
39. Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours.
Etrych T; Subr V; Laga R; Ríhová B; Ulbrich K
Eur J Pharm Sci; 2014 Jul; 58():1-12. PubMed ID: 24632485
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release.
Ruan S; Cao X; Cun X; Hu G; Zhou Y; Zhang Y; Lu L; He Q; Gao H
Biomaterials; 2015 Aug; 60():100-10. PubMed ID: 25988725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
